BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28293977)

  • 1. A prospective pilot study on serum cleaved tau protein as a neurological marker in severe traumatic brain injury.
    Pandey S; Singh K; Sharma V; Pandey D; Jha RP; Rai SK; Chauhan RS; Singh R
    Br J Neurosurg; 2017 Jun; 31(3):356-363. PubMed ID: 28293977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of serum total tau following paediatric traumatic brain injury: a case-control study.
    Stukas S; Higgins V; Frndova H; Gill J; Hubara E; Guerguerian AM; Boutis K; Beauchamp M; Farrell C; Babl FE; Delzoppo C; Greenham M; Wilkinson AA; Crichton A; Anderson V; Adeli K; Hutchison J; Wellington C; ; ;
    Lancet Child Adolesc Health; 2019 Aug; 3(8):558-567. PubMed ID: 31231066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing Plasma Phospho Tau, Total Tau, and Phospho Tau-Total Tau Ratio as Acute and Chronic Traumatic Brain Injury Biomarkers.
    Rubenstein R; Chang B; Yue JK; Chiu A; Winkler EA; Puccio AM; Diaz-Arrastia R; Yuh EL; Mukherjee P; Valadka AB; Gordon WA; Okonkwo DO; Davies P; Agarwal S; Lin F; Sarkis G; Yadikar H; Yang Z; Manley GT; Wang KKW; ; Cooper SR; Dams-O'Connor K; Borrasso AJ; Inoue T; Maas AIR; Menon DK; Schnyer DM; Vassar MJ
    JAMA Neurol; 2017 Sep; 74(9):1063-1072. PubMed ID: 28738126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau proteins in serum predict outcome after severe traumatic brain injury.
    Liliang PC; Liang CL; Weng HC; Lu K; Wang KW; Chen HJ; Chuang JH
    J Surg Res; 2010 May; 160(2):302-7. PubMed ID: 19345376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome.
    Zemlan FP; Jauch EC; Mulchahey JJ; Gabbita SP; Rosenberg WS; Speciale SG; Zuccarello M
    Brain Res; 2002 Aug; 947(1):131-9. PubMed ID: 12144861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
    Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
    J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Serum Brain-Derived Tau With Clinical Outcome and Longitudinal Change in Patients With Severe Traumatic Brain Injury.
    Gonzalez-Ortiz F; Dulewicz M; Ashton NJ; Kac PR; Zetterberg H; Andersson E; Yakoub Y; Hanrieder J; Turton M; Harrison P; Nellgård B; Karikari TK; Blennow K
    JAMA Netw Open; 2023 Jul; 6(7):e2321554. PubMed ID: 37399012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
    Park SH; Hwang SK
    World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between serum tau, neurological outcome, and cognition following traumatic brain injury.
    Ni P; Qiao Y; Tong W; Zhao C; Zheng P
    Neurol India; 2020; 68(2):462-467. PubMed ID: 32415025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury.
    Bogoslovsky T; Wilson D; Chen Y; Hanlon D; Gill J; Jeromin A; Song L; Moore C; Gong Y; Kenney K; Diaz-Arrastia R
    J Neurotrauma; 2017 Jan; 34(1):66-73. PubMed ID: 27312416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum τ protein as a potential biomarker in the assessment of traumatic brain injury.
    Wang J; Li J; Han L; Guo S; Wang L; Xiong Z; Chen Z; Chen W; Liang J
    Exp Ther Med; 2016 Mar; 11(3):1147-1151. PubMed ID: 26998051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage.
    Kellermann I; Kleindienst A; Hore N; Buchfelder M; Brandner S
    Clin Neurol Neurosurg; 2016 Jun; 145():79-83. PubMed ID: 27101088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.
    Gatson JW; Barillas J; Hynan LS; Diaz-Arrastia R; Wolf SE; Minei JP
    J Neurosurg; 2014 Nov; 121(5):1232-8. PubMed ID: 25192482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau protein as a serum marker of brain damage in mild traumatic brain injury: preliminary results.
    Bulut M; Koksal O; Dogan S; Bolca N; Ozguc H; Korfali E; Ilcol YO; Parklak M
    Adv Ther; 2006; 23(1):12-22. PubMed ID: 16644603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderate and severe traumatic brain injury: effect of blood alcohol concentration on Glasgow Coma Scale score and relation to computed tomography findings.
    Rundhaug NP; Moen KG; Skandsen T; Schirmer-Mikalsen K; Lund SB; Hara S; Vik A
    J Neurosurg; 2015 Jan; 122(1):211-8. PubMed ID: 25361494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and Diagnostic Utility of Serum Biomarkers in Pediatric Traumatic Brain Injury.
    Munoz Pareja JC; de Rivero Vaccari JP; Chavez MM; Kerrigan M; Pringle C; Guthrie K; Swaby K; Coto J; Kobeissy F; Avery KL; Ghosh S; Dhanashree R; Shanmugham P; Lautenslager LA; Faulkenberry S; Pareja Zabala MC; Al Fakhri N; Loor-Torres R; Governale LS; Blatt JE; Gober J; Perez PK; Solano J; McCrea H; Thorson C; O'Phelan KH; Keane RW; Dietrich WD; Wang KK
    J Neurotrauma; 2024 Jan; 41(1-2):106-122. PubMed ID: 37646421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and temporal profile of recovery in patients with favorable outcomes at 6 months after severe traumatic brain injury.
    Vedantam A; Robertson CS; Gopinath SP
    J Neurosurg; 2018 Jul; 129(1):234-240. PubMed ID: 28937323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau protein as a diagnostic marker for diffuse axonal injury.
    Tomita K; Nakada TA; Oshima T; Motoshima T; Kawaguchi R; Oda S
    PLoS One; 2019; 14(3):e0214381. PubMed ID: 30901365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Glasgow Coma Scale Using Serum Factors as a Prognostic Model in Traumatic Brain Injury.
    Bae IS; Chun HJ; Yi HJ; Bak KH; Choi KS; Kim DW
    World Neurosurg; 2019 Jun; 126():e959-e964. PubMed ID: 30876987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of long-term (median 10.5 years) outcomes in children presenting with traumatic brain injury and an initial Glasgow Coma Scale score of 3 or 4.
    Fulkerson DH; White IK; Rees JM; Baumanis MM; Smith JL; Ackerman LL; Boaz JC; Luerssen TG
    J Neurosurg Pediatr; 2015 Oct; 16(4):410-9. PubMed ID: 26140392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.